- Home
- CRTO vs IRMD Comparison
CRTO vs IRMD Comparison
Compare CRTO & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRTO | IRMD |
|---|---|---|
| Founded | 2005 | 1992 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 910.4M |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CRTO | IRMD |
|---|---|---|
| Price | $19.74 | $92.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $38.67 | ★ $72.00 |
| AVG Volume (30 Days) | ★ 447.8K | 80.1K |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 0.73% |
| EPS Growth | ★ 83.79 | 13.00 |
| EPS | ★ 3.00 | 1.65 |
| Revenue | ★ $1,956,800,000.00 | $80,511,268.00 |
| Revenue This Year | N/A | $12.93 |
| Revenue Next Year | $1.84 | $11.26 |
| P/E Ratio | ★ $6.57 | $56.50 |
| Revenue Growth | 0.53 | ★ 12.91 |
| 52 Week Low | $19.15 | $47.48 |
| 52 Week High | $47.27 | $93.43 |
Technical Indicators
Market Signals| Indicator | CRTO | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 39.12 | 73.91 |
| Support Level | $19.15 | $82.64 |
| Resistance Level | $20.22 | $93.05 |
| Average True Range (ATR) | 0.78 | 2.31 |
| MACD | -0.16 | 0.40 |
| Stochastic Oscillator | 15.06 | 95.29 |
Price Performance
Historical ComparisonAbout CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.